Campari stock gets a higher UBS target at EUR 7.00

Campari (ISIN NL0015435975) was trading at EUR 5.95 at Lang & Schwarz on September 29, 2026, at 1:41 p.m. CEST. The central valuation signal remains the September 14 analyst reset, when UBS raised its target from EUR 6.10 to EUR 7.00 and Morgan Stanley moved from Equal Weight to Overweight with a EUR 6.50 target, as Investing.com reported on September 14, 2026.

UBS sets a higher target

The UBS target represents a 14.75 percent increase from its previous EUR 6.10 level. Against the EUR 5.95 Lang & Schwarz price, the EUR 7.00 target lies 17.65 percent above the stock price, while Morgan Stanley's EUR 6.50 target lies 9.24 percent above it.

The two upgrades put valuation and execution at the center of the Campari debate. UBS linked its view to aperitif portfolio expansion and new product formats, while Morgan Stanley cited prospects for revenue growth, earnings expansion and improved financial leverage, according to Investing.com.

H1 growth adds operating support

Campari's H1 2026 organic sales rose 2.7 percent, and Sarti Rosa sales increased 8.8 percent, according to The Spirits Business. The figures give the analyst upgrades an operating reference: the investment case depends on turning brand expansion into sustained organic growth rather than relying only on a lower valuation.

Campari's investor materials identify the half-year report at June 30, 2026, and the company announced those H1 results on July 29, 2026, through its Campari Group investor page. The next scheduled earnings release is October 27, 2026, according to Marketscreener.

Stock sits below its yearly high

At EUR 5.95, Campari was 12.76 percent below its 52-week high of EUR 6.82 and EUR 0.68 above its 52-week low of EUR 5.27 on September 29, 2026. Market capitalization stood at EUR 7.1 billion, with 1,482,324 shares traded in the primary-market quote snapshot.

More news and analyses on Campari stock